Koyfin Home > Directory > Health Care > LA Jolla Pharma > Total Debt / Capital

LA Jolla Pharma Total Debt / Capital Chart (LJPC)

LA Jolla Pharma annual/quarterly Total Debt / Capital from 2018 to 2020.
  • LA Jolla Pharma Total Debt / Capital for the quarter ending June 06, 2020 was $198m a 34.44% increase of 68m year over year
  • LA Jolla Pharma Total Debt / Capital for the last 12 months ending June 06, 2020 was $198m a 34.44% increase of 68m year over year
  • LA Jolla Pharma Annual Total Debt / Capital for 2019 was $157m a 50.69% increase of 80m from 2018
  • LA Jolla Pharma Annual Total Debt / Capital for 2018 was $78m
Other Ratios Metrics:
  • LA Jolla Pharma Other Liabilities for the quarter ending December 12, 2018 was $14m a 1.00% increase of 0m year over year
  • LA Jolla Pharma Total Debt / Equity for the quarter ending September 09, 2018 was $166m a 96.77% increase of 160m year over year
View Chart On Koyfin

Quarterly LJPC Total Debt / Capital Data

06/2020$198m
03/2020$168m
12/2019$157m
09/2019$130m
06/2019$109m
03/2019$93m
12/2018$78m
09/2018$62m
06/2018$52m

Annual LJPC Total Debt / Capital Data

2019$157m
2018$78m